Baseline Platelet Count Predicts Infarct Size and Mortality after Acute Myocardial Infarction
- 4 October 2024
- journal article
- research article
- Published by Georg Thieme Verlag KG in Hamostaseologie
Abstract
Introduction Platelets greatly contribute to cardiovascular diseases. We sought to explore the association of platelet counts with infarct size and outcome in patients presenting with acute ST-segment elevation MI (STEMI) treated with primary percutaneous coronary intervention (PPCI). Methods and Results In this retrospective study, we grouped 1,198 STEMI patients into tertiles (T) based on platelet count on admission: T1 = 102–206 [109 platelets/L] (n = 402), T2 = 207–259 [109 platelets/L] (n = 396), and T3 = 260–921 [109 platelets/L] (n = 400). Primary endpoint was 1-year all-cause mortality. Patients with highest platelet counts on admission showed the greatest area at risk and infarct size: area at risk (median) was 22.0% (interquartile range [IQR]: 12.0–39.8%) in T1, 21.0% (IQR: 11.0–37.1%) in T2, and 26.0% (IQR: 14.9–45.0%) of the left ventricle in T3 (p = 0.003); final infarct sizes after 7 to 14 days were as follows: 10.0% (IQR: 2.0–21.0%) in T1, 9.0% (IQR: 2.0–20.7%) in T2, and 12.0% (IQR: 3.0–27.3%) of the left ventricle in T3 (p = 0.015) as serial imaging revealed. At 1 year, 16 all-cause deaths occurred in T1, 5 in T2, and 22 in T3 (log-rank test, p = 0.006). After adjustment, T1 and T3 were associated with all-cause 1-year mortality (T1: hazard ratio [HR] = 3.40, 95% confidence interval [CI] = 1.23–9.54, p = 0.02; T3: HR = 3.55, 95% CI = 1.23–9.78, p = 0.01) compared with T2. At 5 years, all-cause mortality remained numerically higher in the T1 and T3. Conclusions In patients with STEMI undergoing PPCI, low and high blood platelet levels on admission were associated with increased long-term mortality ([Fig. 1]). * These authors contributed equally. Received: 09 January 2024 Accepted: 01 April 2024 Article published online: 04 October 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Stuttgart · New YorkKeywords
Funding Information
- European Research Council under the European Union's Horizon 2020 Research and Innovation Programme (759272)
- Else-Kröner-Fresenius-Stiftung (2020_EKSE.07)
- Deutsche Forschungsgemeinschaft (515567441)
- Deutsche Forschungsgemeinschaft (470462396)
- Deutsche Forschungsgemeinschaft (CRC 1123 (B11))
This publication has 17 references indexed in Scilit:
- 2023 ESC Guidelines for the management of acute coronary syndromesEuropean Heart Journal: Acute Cardiovascular Care, 2023
- Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammationNature Cardiovascular Research, 2022
- Blood Platelet Count at Hospital Admission Impacts Long-Term Mortality in Patients with Acute Coronary SyndromeCardiology, 2020
- Platelet biology and functions: new concepts and clinical perspectivesNature Reviews Cardiology, 2018
- Do platelets promote cardiac recovery after myocardial infarction: roles beyond occlusive ischemic damageAmerican Journal of Physiology-Heart and Circulatory Physiology, 2018
- Safety and Antithrombotic Efficacy of Moderate Platelet Count Reduction by Thrombopoietin Inhibition in PrimatesScience Translational Medicine, 2010
- 5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial InfarctionJACC, 2010
- Impact of Baseline Platelet Count in Patients Undergoing Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction (from the CADILLAC Trial)The American Journal of Cardiology, 2007
- Association of Platelet Counts on Presentation and Clinical Outcomes in ST-Elevation Myocardial Infarction (from the TIMI Trials)The American Journal of Cardiology, 2006
- The impact of platelet count on mortality in unstable angina/non–ST-segment elevation myocardial infarctionAmerican Heart Journal, 2006